02:02 PM EDT, 08/08/2025 (MT Newswires) -- Oncolytics Biotech ( ONCY ) was last seen down 2.4% after the company said it is voluntarily delisting from the Toronto Stock Exchange (TSX) at the close of markets on August 22.

The company said with the de-listing, it will cease to be treated as a Foreign Private Issuer for purposes of U.S. federal securities laws, effective January 1, 2026, and is considering re-domiciling to the U.S. in the future. It also said that benefits associated with maintaining a secondary listing on the TSX "do not justify" the direct and indirect costs given its U.S. focus and its U.S. shareholder base.

Shares of the company will continue to trade on the Nasdaq Exchange under the symbol "ONCY" after de-listing from the TSX.

Oncolytics Biotech ( ONCY ) shares were last seen down $0.03 at $1.23 on the TSX.

Price: 1.22, Change: -0.04, Percent Change: -3.17